Varenicline: for smoking cessation.

@article{Rao2009VareniclineFS,
  title={Varenicline: for smoking cessation.},
  author={J. Rao and P. K. Shankar},
  journal={Kathmandu University medical journal},
  year={2009},
  volume={7 26},
  pages={
          162-4
        }
}
  • J. Rao, P. K. Shankar
  • Published 2009
  • Medicine
  • Kathmandu University medical journal
    • Varenicline, a partial agonist of alpha4beta2 nicotinic acetylcholine receptor (nAChR), is the most recently approved drug for smoking cessation. Despite the availability of effective treatments for smoking cessation, such as nicotine replacement therapy and Bupropion sustained-release, abstinence rates remain less than optimal. As a nAChR partial agonist, Varenicline attenuates the craving and withdrawal symptoms that occur with abstinence from nicotine and also reduces the rewarding effects… CONTINUE READING
    View PDF
    30 Citations
    Highly Influential Citations
    2
    Background Citations
    7
    30 Citations
    Citation Type

    Citation Type

    [Smoking cessation: Pharmacological strategies different from standard treatments].
    • 1
    Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    • 77
    • PDF
    Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
    • 304
    • PDF
    A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.
    • 22
    • PDF
    ▼Varenicline for smoking cessation
    • 3
    • PDF
    Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice
    • 71
    Adherence to Varenicline and Abstinence Rates for Quitting Smoking in a Private Health Promotion Center-Based Smoking Cessation Clinic
    • 10
    • PDF
    Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    • 44
    • PDF
    Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    • 203
    • Highly Influenced
    • PDF
    Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial
    • PDF

    References

    SHOWING 1-10 OF 18 REFERENCES
    Varenicline for smoking cessation
    • S. Tonstad
    • Medicine
    • Expert review of neurotherapeutics
    • 2007
    • 14
    • PDF
    Varenicline: a review of its use as an aid to smoking cessation therapy.
    • 46
    Efficacy of Varenicline , an 4 2 Nicotinic Acetylcholine Receptor Partial Agonist , vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial
    • 270
    • PDF
    Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial
    • 1,155
    • PDF
    Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial
    • 1,243
    • PDF
    Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    • 364
    • PDF
    Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    • 356
    • PDF
    Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    • 609
    • PDF
    Pharmacotherapy for Nicotine Dependence 1
    • 203
    • PDF
    Nicotine replacement therapy for smoking cessation.
    • 949